ALT

Altimmune Stock Price

13.38
0.64 (5.02%)
13.38

Low
4.20

52 Week Range

High
35.10

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Basic
Monthly Subscription
for only
$33.03
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
VAT not included
Company Name Stock Ticker Symbol Market Type
Altimmune Inc ALT NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.64 5.02% 13.38 16:43:52
Open Price Low Price High Price Close Price Prev Close
12.80 12.60 13.50 13.38 12.74
Bid Price Ask Price Spread News
13.24 13.90 0.66 - -
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
5,559 677,367 $ 13.13 $ 8,896,199 895,272 4.20 - 35.10
Last Trade Time Type Quantity Stock Price Currency
16:42:29 1 $ 13.55 USD

Altimmune Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 497.07M 37.15M 32.20M $ 8.19M $ - -1.91 -6.70
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - -6.57k 13.70%

more financials information »

Altimmune News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical ALT Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week12.9813.9112.200113.06676,0060.403.08%
1 Month12.4814.9511.3513.23885,1170.907.21%
3 Months23.7524.0311.3515.241,249,315-10.37-43.66%
6 Months9.3724.618.7614.651,573,2804.0142.8%
1 Year5.1035.104.2015.272,507,0468.28162.35%
3 Years0.5536.250.24510.511,383,71812.832,332.73%
5 Years7.3136.250.24510.101,085,9586.0783.04%

Altimmune Description

Altimmune Inc is a United States-based clinical-stage immunotherapeutic biotechnology company. It is involved in the business of developing products that engage, stimulate and improve immune responses for the prevention and treatment of liver diseases. The firm's product candidates include NasoVAX, HepTcell, ALT-801, T-COVID, and NasoShield. It also develops platform technologies such as RespirVec and Densigen. The company generates its revenue from cost plus fee contracts and fixed-price contracts.


Your Recent History
NASDAQ
ALT
Altimmune
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.